drugset
drugset / Trial / NCT03647917

A Pilot Study on the Use of Platelet Rich Plasma (PRP) for Facial and Hand Skin Rejuvenation

NCT03647917 ↗

Phase 0 Completed 12 enrolled Mayo Clinic
RandomizedSingle-groupSingle-blindTreatment

Summary

The overall goal of this study is to develop regenerative cell therapy for use in female patients with aging skin. The primary objective of this proposal is to conduct a pilot study on the efficacy and safety of using PRP to treat this condition in females.

Timeline

Start
2019-06-18
Primary completion
2021-06-07
Completion
2021-06-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified 1 ml Other
Subject Platelet Rich Plasma Other / unclassified 3.5 ml Other

Indications

No indication recorded.